drugset / Trial / NCT01856140

Treatment of Tendon Injury Using Mesenchymal Stem Cells

NCT01856140

Non-randomizedParallel-groupOpen-labelTreatment

Summary

Main purpose of this study is to evaluate efficacy and safety of allogenic adipose-derived mesenchymal stem cells(ALLO-ASC) in treatment of tendon injury. ALLO-ASC will be administrated to the patients with lateral epicondylitis by ultrasonographic guided injection.

Timeline

Start
2013-05
Primary completion
2016-07
Completion
2018-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject ALLO-ASC Cell therapy 1 unknown
Subject ALLO-ASC Cell therapy 10 unknown

Indications